{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:19:31Z","timestamp":1778858371714,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Progression in multiple sclerosis (MS) often corresponds to irreversible disability in MS patients. Cellular changes in the cerebrospinal fluid (CSF) have provided biomarkers and mechanisms in relapsing-remitting MS (RRMS) but remain understudied in primary and secondary progressive MS (summarized herein as PMS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We combined retrospective flow cytometry of CSF cells from RRMS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009169), PMS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200956), and non-inflammatory controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200974) with prospective CSF single-cell transcriptomics of 35 individuals (11 controls, 12 RRMS, and 12 PMS) and with confirmatory CSF ELISA. Available CSF single-cell data from age-matched and Alzheimer\u2019s disease (AD) patients served as additional controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Proportions of CD14\n                      <jats:sup>+<\/jats:sup>\n                      monocytes in CSF are increased in PMS and correlated with clinical surrogate markers of progression. Transcriptionally, these monocytes resembled border-associated macrophages (BAM)-like cells with a chronically activated antigen-presenting phenotype. Additionally, these monocytes shared some features with disease-associated microglia\/macrophages (DAM), previously identified in neurodegeneration. Induction of DAM-associated molecules, including transcribed and soluble TREM2 (sTREM2), characterized secondary progressive MS (SPMS) and supported its differential diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>We thus identified MS stage-specific CSF signatures and shared cellular features of degeneration detectable in CSF of PMS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-026-03861-9","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:54:02Z","timestamp":1778644442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A CSF disease-associated macrophage signature defines progressive multiple sclerosis"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-8652","authenticated-orcid":false,"given":"Anna-Lena","family":"B\u00f6rsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3463-6491","authenticated-orcid":false,"given":"Frederike","family":"Riethues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3855-4706","authenticated-orcid":false,"given":"Andreas","family":"Schulte-Mecklenbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6049-1499","authenticated-orcid":false,"given":"Xuesong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9568-2790","authenticated-orcid":false,"given":"Michael","family":"Heming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Na","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5689-585X","authenticated-orcid":false,"given":"Louisa","family":"M\u00fcller-Miny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4310-3432","authenticated-orcid":false,"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4872-9189","authenticated-orcid":false,"given":"Catharina C.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-344X","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Bernard-Valnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4341-4719","authenticated-orcid":false,"given":"Gerd","family":"Meyer zu H\u00f6rste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"3861_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1474-4422(06)70410-0","volume":"5","author":"M Rovaris","year":"2006","unstructured":"Rovaris M, et al. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol. 2006;5:343\u201354.","journal-title":"Lancet Neurol"},{"key":"3861_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/jnnp-2025-335958","volume":"96","author":"A Zangh\u00ec","year":"2025","unstructured":"Zangh\u00ec A, et al. Multiple sclerosis from onset to secondary progression: a 30-year Italian register study. J Neurol Neurosurg Psychiatry. 2025;96:1061\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3861_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/brain\/awl007","volume":"129","author":"C Confavreux","year":"2006","unstructured":"Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain. 2006;129:606\u201316.","journal-title":"Brain"},{"key":"3861_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41582-025-01115-5","volume":"21","author":"A van der Walt","year":"2025","unstructured":"van der Walt A, et al. Advancing multiple sclerosis management in older adults. Nat Rev Neurol. 2025;21:432\u201348.","journal-title":"Nat Rev Neurol"},{"key":"3861_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamaneurol.2025.0495","volume":"82","author":"J M\u00fcller","year":"2025","unstructured":"M\u00fcller J, et al. Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA Neurol. 2025;82:614\u201325.","journal-title":"JAMA Neurol"},{"key":"3861_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","volume":"22","author":"KE Attfield","year":"2022","unstructured":"Attfield KE, Jensen LT, Kaufmann M, Friese MA, Fugger L. The immunology of multiple sclerosis. Nat Rev Immunol. 2022;22:734\u201350.","journal-title":"Nat Rev Immunol"},{"key":"3861_CR7","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","volume":"76","author":"M Absinta","year":"2019","unstructured":"Absinta M, et al. Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol. 2019;76:1474\u201383.","journal-title":"JAMA Neurol"},{"key":"3861_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","volume":"22","author":"JS Graves","year":"2023","unstructured":"Graves JS, et al. Ageing and multiple sclerosis. Lancet Neurol. 2023;22:66\u201377.","journal-title":"Lancet Neurol"},{"key":"3861_CR9","doi-asserted-by":"publisher","first-page":"100533","DOI":"10.1016\/j.crmeth.2023.100533","volume":"3","author":"H Touil","year":"2023","unstructured":"Touil H, et al. A structured evaluation of cryopreservation in generating single-cell transcriptomes from cerebrospinal fluid. Cell Rep Methods. 2023;3:100533.","journal-title":"Cell Rep Methods"},{"key":"3861_CR10","doi-asserted-by":"publisher","first-page":"e200322","DOI":"10.1212\/NXI.0000000000200322","volume":"12","author":"F Held","year":"2025","unstructured":"Held F, et al. Proteomics reveals age as major modifier of inflammatory CSF signatures in multiple sclerosis. Neurol Neuroimmunol Neuroinflammation. 2025;12:e200322.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"3861_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta M, et al. A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active Multiple Sclerosis. Nature. 2021;597:709\u201314.","journal-title":"Nature"},{"key":"3861_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuron.2024.11.016","volume":"113","author":"W Macnair","year":"2025","unstructured":"Macnair W, et al. snRNA-seq stratifies Multiple Sclerosis patients into distinct white matter glial responses. Neuron. 2025;113:396-410.e9.","journal-title":"Neuron"},{"key":"3861_CR13","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa2415988","volume":"392","author":"RJ Fox","year":"2025","unstructured":"Fox RJ, et al. Tolebrutinib in nonrelapsing secondary progressive multiple sclerosis. N Engl J Med. 2025;392:1883\u201392.","journal-title":"N Engl J Med"},{"key":"3861_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41582-023-00800-7","volume":"19","author":"J Kr\u00e4mer","year":"2023","unstructured":"Kr\u00e4mer J, Bar-Or A, Turner TJ, Wiendl H. Bruton tyrosine kinase inhibitors for multiple sclerosis. Nat Rev Neurol. 2023;19:289\u2013304.","journal-title":"Nat Rev Neurol"},{"key":"3861_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41467-019-14118-w","volume":"11","author":"D Schafflick","year":"2020","unstructured":"Schafflick D, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247.","journal-title":"Nat Commun"},{"key":"3861_CR16","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/brain\/awab147","volume":"144","author":"CC Gross","year":"2021","unstructured":"Gross CC, et al. Classification of neurological diseases using multi-dimensional CSF analysis. Brain. 2021;144:2625\u201334.","journal-title":"Brain"},{"key":"3861_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162\u201373.","journal-title":"Lancet Neurol"},{"key":"3861_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, et al. Defining the clinical course of Multiple Sclerosis. Neurology. 2014;83:278\u201386.","journal-title":"Neurology"},{"key":"3861_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-023-02733-w","volume":"20","author":"M Heming","year":"2023","unstructured":"Heming M, et al. Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry. J Neuroinflammation. 2023;20:46.","journal-title":"J Neuroinflammation"},{"key":"3861_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/ana.27157","volume":"97","author":"M Heming","year":"2025","unstructured":"Heming M, et al. Atlas of cerebrospinal fluid immune cells across neurological diseases. Ann Neurol. 2025;97:779\u201390.","journal-title":"Ann Neurol"},{"key":"3861_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.immuni.2020.12.011","volume":"54","author":"M Heming","year":"2021","unstructured":"Heming M, et al. Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid. Immunity. 2021;54:164-175.e6.","journal-title":"Immunity"},{"key":"3861_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12974-022-02667-9","volume":"19","author":"F Straeten","year":"2022","unstructured":"Straeten F, et al. Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-na\u00efve multiple sclerosis. J Neuroinflammation. 2022;19:306.","journal-title":"J Neuroinflammation"},{"key":"3861_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-021-00423-w","volume":"16","author":"H Oh","year":"2021","unstructured":"Oh H, et al. Methods to investigate intrathecal adaptive immunity in neurodegeneration. Mol Neurodegener. 2021;16:3.","journal-title":"Mol Neurodegener"},{"key":"3861_CR24","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1093\/brain\/awaf096","volume":"148","author":"D Esser","year":"2025","unstructured":"Esser D, et al. Activated \u03b1\u03b2 T and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis. Brain J Neurol. 2025;148:3170\u201383.","journal-title":"Brain J Neurol"},{"key":"3861_CR25","doi-asserted-by":"publisher","unstructured":"RogozhnikovA. et al. Demuxalot: scaled up genetic demultiplexing for single-cell sequencing. 2021.05.22.443646 Preprint at 2021. https:\/\/doi.org\/10.1101\/2021.05.22.443646.","DOI":"10.1101\/2021.05.22.443646"},{"key":"3861_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street K, et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics. 2018;19:477.","journal-title":"BMC Genomics"},{"key":"3861_CR27","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1093\/bioinformatics\/btac582","volume":"38","author":"B Phipson","year":"2022","unstructured":"Phipson B, et al. propeller: testing for differences in cell type proportions in single cell data. Bioinforma Oxf Engl. 2022;38:4720\u20136.","journal-title":"Bioinforma Oxf Engl"},{"key":"3861_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J Integr Biol. 2012;16:284\u20137.","journal-title":"Omics J Integr Biol"},{"key":"3861_CR29","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1016\/j.cell.2022.11.019","volume":"185","author":"N Piehl","year":"2022","unstructured":"Piehl N, et al. Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment. Cell. 2022;185:5028-5039.e13.","journal-title":"Cell"},{"key":"3861_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature. 2020;577:399\u2013404.","journal-title":"Nature"},{"key":"3861_CR31","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov Camb Mass. 2021;2:100141.","journal-title":"Innov Camb Mass"},{"key":"3861_CR32","doi-asserted-by":"publisher","first-page":"22932","DOI":"10.1073\/pnas.2008523117","volume":"117","author":"A Ramesh","year":"2020","unstructured":"Ramesh A, et al. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proc Natl Acad Sci U S A. 2020;117:22932\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3861_CR33","doi-asserted-by":"publisher","first-page":"eadc9778","DOI":"10.1126\/scitranslmed.adc9778","volume":"14","author":"P Ostkamp","year":"2022","unstructured":"Ostkamp P, et al. A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis. Sci Transl Med. 2022;14:eadc9778.","journal-title":"Sci Transl Med"},{"key":"3861_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12974-024-03047-1","volume":"21","author":"MC Kodali","year":"2024","unstructured":"Kodali MC, et al. Cryopreservation of cerebrospinal fluid cells preserves the transcriptional landscape for single-cell analysis. J Neuroinflammation. 2024;21:71.","journal-title":"J Neuroinflammation"},{"key":"3861_CR35","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566-581.e9.","journal-title":"Immunity"},{"key":"3861_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E Morenas-Rodr\u00edguez","year":"2022","unstructured":"Morenas-Rodr\u00edguez E, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study. Lancet Neurol. 2022;21:329\u201341.","journal-title":"Lancet Neurol"},{"key":"3861_CR37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.15252\/embr.201743922","volume":"18","author":"F Mazaheri","year":"2017","unstructured":"Mazaheri F, et al. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep. 2017;18:1186\u201398.","journal-title":"EMBO Rep"},{"key":"3861_CR38","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169:1276-1290.e17.","journal-title":"Cell"},{"key":"3861_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L, Xiang X, Li Y, Bu G, Chen X-F. TREM2 and sTREM2 in Alzheimer\u2019s disease: from mechanisms to therapies. Mol Neurodegener. 2025;20:43.","journal-title":"Mol Neurodegener"},{"key":"3861_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12974-022-02408-y","volume":"19","author":"E Kamma","year":"2022","unstructured":"Kamma E, Lasisi W, Libner C, Ng HS, Plemel JR. Central nervous system macrophages in progressive Multiple Sclerosis: relationship to neurodegeneration and therapeutics. J Neuroinflammation. 2022;19:45.","journal-title":"J Neuroinflammation"},{"key":"3861_CR41","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.immuni.2022.07.004","volume":"55","author":"A Silvin","year":"2022","unstructured":"Silvin A, et al. Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration. Immunity. 2022;55:1448-1465.e6.","journal-title":"Immunity"},{"key":"3861_CR42","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1146\/annurev-immunol-082423-041334","volume":"43","author":"H Van Hove","year":"2025","unstructured":"Van Hove H, De Feo D, Greter M, Becher B. Central nervous system macrophages in health and disease. Annu Rev Immunol. 2025;43:589\u2013613.","journal-title":"Annu Rev Immunol"},{"key":"3861_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-immunol-093019-110159","volume":"39","author":"M Prinz","year":"2021","unstructured":"Prinz M, Masuda T, Wheeler MA, Quintana FJ. Microglia and central nervous system-associated macrophages-from origin to disease modulation. Annu Rev Immunol. 2021;39:251\u201377.","journal-title":"Annu Rev Immunol"},{"key":"3861_CR44","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.immuni.2025.04.005","volume":"58","author":"M Vara-P\u00e9rez","year":"2025","unstructured":"Vara-P\u00e9rez M, Movahedi K. Border-associated macrophages as gatekeepers of brain homeostasis and immunity. Immunity. 2025;58:1085\u2013100.","journal-title":"Immunity"},{"key":"3861_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12974-024-03059-x","volume":"21","author":"R Sun","year":"2024","unstructured":"Sun R, Jiang H. Border-associated macrophages in the central nervous system. J Neuroinflammation. 2024;21:67.","journal-title":"J Neuroinflammation"},{"key":"3861_CR46","doi-asserted-by":"publisher","first-page":"101733","DOI":"10.1016\/j.xcrm.2024.101733","volume":"6","author":"BM Jacobs","year":"2025","unstructured":"Jacobs BM, et al. Single-cell analysis of cerebrospinal fluid reveals common features of neuroinflammation. Cell Rep Med. 2025;6:101733.","journal-title":"Cell Rep Med"},{"key":"3861_CR47","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/s41591-025-03625-7","volume":"31","author":"L Klotz","year":"2025","unstructured":"Klotz L, et al. Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis. Nat Med. 2025;31:2016\u201326.","journal-title":"Nat Med"},{"key":"3861_CR48","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.26448","volume":"92","author":"R Magliozzi","year":"2022","unstructured":"Magliozzi R, et al. \u2018Ependymal-in\u2019 gradient of thalamic damage in progressive multiple sclerosis. Ann Neurol. 2022;92:670\u201385.","journal-title":"Ann Neurol"},{"key":"3861_CR49","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41423-023-01053-6","volume":"20","author":"A Silvin","year":"2023","unstructured":"Silvin A, Qian J, Ginhoux F. Brain macrophage development, diversity and dysregulation in health and disease. Cell Mol Immunol. 2023;20:1277\u201389.","journal-title":"Cell Mol Immunol"},{"key":"3861_CR50","doi-asserted-by":"publisher","first-page":"e70480","DOI":"10.1111\/ene.70480","volume":"33","author":"N Fissolo","year":"2026","unstructured":"Fissolo N, et al. Serum sTREM2 levels and disability progression in patients with Primary Progressive Multiple Sclerosis. Eur J Neurol. 2026;33:e70480.","journal-title":"Eur J Neurol"},{"key":"3861_CR51","doi-asserted-by":"crossref","unstructured":"Veroni C. et al. Connecting Immune cell infiltration to the multitasking microglia response and TNF receptor 2 induction in the multiple sclerosis brain. Front Cell Neurosci 2020;14.","DOI":"10.3389\/fncel.2020.00190"},{"key":"3861_CR52","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/glia.20468","volume":"55","author":"A Sierra","year":"2007","unstructured":"Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia. 2007;55:412\u201324.","journal-title":"Glia"},{"key":"3861_CR53","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23:194\u2013208.","journal-title":"Nat Neurosci"},{"key":"3861_CR54","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nn.4222","volume":"19","author":"K Grabert","year":"2016","unstructured":"Grabert K, et al. Microglial brain region\u2212dependent diversity and selective regional sensitivities to aging. Nat Neurosci. 2016;19:504\u201316.","journal-title":"Nat Neurosci"},{"key":"3861_CR55","doi-asserted-by":"publisher","first-page":"e1094","DOI":"10.1212\/NXI.0000000000001094","volume":"8","author":"M Eschborn","year":"2021","unstructured":"Eschborn M, et al. Evaluation of age-dependent immune signatures in patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflammation. 2021;8:e1094.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"3861_CR56","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nn.3554","volume":"16","author":"SE Hickman","year":"2013","unstructured":"Hickman SE, et al. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci. 2013;16:1896\u2013905.","journal-title":"Nat Neurosci"},{"key":"3861_CR57","doi-asserted-by":"publisher","first-page":"19471","DOI":"10.1038\/s41598-022-21920-y","volume":"12","author":"AL Thomas","year":"2022","unstructured":"Thomas AL, Lehn MA, Janssen EM, Hildeman DA, Chougnet CA. Naturally-aged microglia exhibit phagocytic dysfunction accompanied by gene expression changes reflective of underlying neurologic disease. Sci Rep. 2022;12:19471.","journal-title":"Sci Rep"},{"key":"3861_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-024-02730-0","volume":"147","author":"A Geladaris","year":"2024","unstructured":"Geladaris A, et al. BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair. Acta Neuropathol. 2024;147:75.","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03861-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03861-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03861-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:04:43Z","timestamp":1778857483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03861-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3861"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03861-9","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved by the\n                      Ethikkommission der \u00c4rztekammer Westfalen-Lippe (\u00c4KWL) und der Westf\u00e4lischen-Wilhelms-Universit\u00e4t\n                      (Ethics Committee of the Board of Physicians of the Region Westfalen-Lippe and of the University M\u00fcnster) under reference number 2015\u2014522\u2014f-S. Samples collected in Lausanne, Switzerland were included in this study under ethical approval granted by the\n                      Commission cantonale d'\u00e9thique de la recherche sur l'\u00eatre humain\n                      (CER-VD) within the framework of the CHOROID study (approval number: 2021\u201402228).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}